Search

everythinglearnresearchcommunity

for

Search:↓

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Lymphoid-specific helicase (Lsh) is crucial for skin growth, change, and healing after injury.

Interleukin 6 may help protect skin without causing inflammation.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

LEF-1 boosts cell growth in goat hair follicles, aiding cashmere production.

SIG-1451 could be a promising new treatment for atopic dermatitis.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Injecting certain cells into mice caused hair loss, which was preventable with a specific inhibitor.

ME1 and PPAR signaling may influence hair loss in androgenetic alopecia.

The study identified key immune cell differences between mild and severe alopecia areata.

A new gene mutation may allow some piebaldism patients to regain skin color in white patches.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

Inhibiting IL-17 and IL-23 improves wound healing in obese, diabetic mice by promoting healing macrophages.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

IL-36α helps grow new hair follicles and speeds up wound healing.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

HPV8 causes hair follicle stem cells to grow, leading to skin lesions.

CXCR2 in skin cells promotes tumor growth.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.